Axoft

Summary active Updated Apr 30, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Cambridge, MA
Founded 2021
Latest Stage Series A
Total Raised $63M
Website https://axoft.bio
Sector
neurotech neuroscience brain-computer-interface medical-devices healthcare

Founders

Paul Le Floch Co-Founder & CEO
Tianyang Ye Co-Founder & CTO
Jia Liu Co-Founder; Assistant Professor, Harvard SEAS

About

Axoft is a Cambridge, Massachusetts-based neurotechnology company developing bio-inspired, implantable brain-computer interfaces (iBCIs) 1. The company was founded in 2021 by Paul Le Floch (CEO), Tianyang Ye (CTO), and Jia Liu, an assistant professor at Harvard’s School of Engineering and Applied Sciences 2.

Axoft’s iBCIs are built using its proprietary Fleuron material, which the company describes as up to 10,000x softer than the polyimide used in existing iBCIs, with 8x more region access, 32x more sensors/stimulators per thread than standard flexible probes, and over 60% less signal attenuation than polyimide 1. The company is pursuing applications in disorders of consciousness, with plans to expand clinical trials globally and pursue U.S. regulatory approval 1.

Funding History

Date Round Amount Lead Co-investors
2022-10-21 Seed $8M The Engine 2
2026-04-29 Series A $55M C.P. Group Innovation Alumni Ventures, Stanford President’s Venture Fund, Hillhouse Investment, Gaorong Ventures 13

Total funding raised to date: more than $60M 1.

What Investors Say

No independently sourced investor quotes found at this time.

What Founders Say

“Better neural signals are the foundation everything else is built on.” — Paul Le Floch, Co-Founder and CEO, on Axoft’s approach to enabling minimally invasive procedures and next-generation AI decoding 1.

Sources

  1. “Axoft Secures $55M Series A to Advance Clinical Trials Globally for its Bio-Inspired, Implantable Brain-Computer Interface,” BusinessWire / BioSpace, April 29, 2026. Accessed April 2026. https://www.biospace.com/press-releases/axoft-secures-55m-series-a-to-advance-clinical-trials-globally-for-its-bio-inspired-implantable-brain-computer-interface↩↩↩↩↩↩

  2. “Neural Implant Startup Axoft Raises $8M,” Built In Boston, October 21, 2022. Accessed April 2026. https://www.builtinboston.com/articles/axoft-neurotechnology-brain-machine-interface↩↩

  3. “Axoft Secures $55M Series A to Advance Clinical Trials Globally for its Bio-Inspired, Implantable Brain-Computer Interface,” BusinessWire, April 29, 2026. Accessed April 2026. https://www.businesswire.com/news/home/20260429285106/en/Axoft-Secures-%2455M-Series-A-to-Advance-Clinical-Trials-Globally-for-its-Bio-Inspired-Implantable-Brain-Computer-Interface↩